Header Logo

Connection

DAVID GRAHAM to Metaplasia

Back to Details
This is a "connection" page, showing publications DAVID GRAHAM has written about Metaplasia.
DAVID GRAHAM
Connection Strength
1.714
Metaplasia
  1. Operative link for gastritis assessment vs operative link on intestinal metaplasia assessment. World J Gastroenterol. 2011 Nov 07; 17(41):4596-601.
    View in: PubMed
    Score: 0.347
  2. Histologic and serum risk markers for noncardia early gastric cancer. Int J Cancer. 2005 Jun 20; 115(3):463-9.
    View in: PubMed
    Score: 0.223
  3. Autoimmune gastritis: long-term natural history in na?ve Helicobacter pylori-negative patients. Gut. 2023 01; 72(1):30-38.
    View in: PubMed
    Score: 0.181
  4. Guilt by association: intestinal metaplasia does not progress to gastric cancer. Curr Opin Gastroenterol. 2018 11; 34(6):458-464.
    View in: PubMed
    Score: 0.141
  5. Time Trends in Helicobacter pylori Infection and Atrophic Gastritis Over 40 Years in Japan. Helicobacter. 2015 Jun; 20(3):192-8.
    View in: PubMed
    Score: 0.108
  6. Histological risk markers for non-cardia early gastric cancer. Pattern of mucin expression and gastric cancer. Virchows Arch. 2006 Dec; 449(6):652-9.
    View in: PubMed
    Score: 0.061
  7. CagA in Barrett's oesophagus in Colombia, a country with a high prevalence of gastric cancer. J Clin Pathol. 2005 Mar; 58(3):259-62.
    View in: PubMed
    Score: 0.055
  8. Gastric intestinal metaplasia: subtypes and natural history. J Clin Pathol. 2001 Sep; 54(9):679-83.
    View in: PubMed
    Score: 0.043
  9. Cytokeratin subsets for distinguishing Barrett's esophagus from intestinal metaplasia in the cardia using endoscopic biopsy specimens. Am J Gastroenterol. 2001 May; 96(5):1378-82.
    View in: PubMed
    Score: 0.042
  10. Screening and eradication of Helicobacter pylori for gastric cancer prevention: the Taipei global consensus. Gut. 2020 12; 69(12):2093-2112.
    View in: PubMed
    Score: 0.040
  11. The gastric cardia in gastro-oesophageal disease. J Clin Pathol. 2000 Aug; 53(8):619-25.
    View in: PubMed
    Score: 0.040
  12. Pathogenesis of duodenal ulcer disease: the rest of the story. Baillieres Best Pract Res Clin Gastroenterol. 2000 Feb; 14(1):97-107.
    View in: PubMed
    Score: 0.038
  13. A reliable method for the simultaneous identification of H pylori and gastric metaplasia in the duodenum. J Clin Pathol. 1999 Dec; 52(12):914-6.
    View in: PubMed
    Score: 0.038
  14. Accuracy of endoscopic staging and targeted biopsies for routine gastric intestinal metaplasia and gastric atrophy evaluation study protocol of a prospective, cohort study: the estimate study. BMJ Open. 2019 09 18; 9(9):e032013.
    View in: PubMed
    Score: 0.037
  15. Evaluation of gastric mucosal biopsy site and number for identification of Helicobacter pylori or intestinal metaplasia: role of the Sydney System. Hum Pathol. 1999 Jan; 30(1):72-7.
    View in: PubMed
    Score: 0.036
  16. Immunohistochemical assessment of Survivin and Bcl3 expression as potential biomarkers for NF-?B activation in the Barrett metaplasia-dysplasia-adenocarcinoma sequence. Int J Exp Pathol. 2018 02; 99(1):10-14.
    View in: PubMed
    Score: 0.034
  17. Histological features do not define NSAID-induced gastritis. Hum Pathol. 1996 Dec; 27(12):1348-54.
    View in: PubMed
    Score: 0.031
  18. Prostate stem cell antigen gene TT genotype and development of intestinal metaplasia in Helicobacter pylori infection. J Dig Dis. 2016 Jan; 17(1):20-7.
    View in: PubMed
    Score: 0.029
  19. Esophageal neoplasia arising from subsquamous buried glands after an apparently successful photodynamic therapy or radiofrequency ablation for Barrett's associated neoplasia. Scand J Gastroenterol. 2015; 50(11):1315-21.
    View in: PubMed
    Score: 0.028
  20. The gastric cardia in Helicobacter pylori infection. Hum Pathol. 1994 Sep; 25(9):915-9.
    View in: PubMed
    Score: 0.026
  21. Intestinal metaplasia, not atrophy or achlorhydria, creates a hostile environment for Helicobacter pylori. Scand J Gastroenterol. 1993 Oct; 28(10):924-8.
    View in: PubMed
    Score: 0.025
  22. Changes in the gastric mucosa following eradication of Helicobacter pylori. Mod Pathol. 1993 May; 6(3):281-9.
    View in: PubMed
    Score: 0.024
  23. Campylobacter pylori and peptic ulcer disease. Gastroenterology. 1989 Feb; 96(2 Pt 2 Suppl):615-25.
    View in: PubMed
    Score: 0.018
  24. Prevalence and determinants of histological abnormalities of the gastric cardia in volunteers. Scand J Gastroenterol. 2007 Oct; 42(10):1158-66.
    View in: PubMed
    Score: 0.016
  25. Geographic differences in the distribution of intestinal metaplasia in duodenal ulcer patients. Am J Gastroenterol. 2001 Mar; 96(3):666-72.
    View in: PubMed
    Score: 0.010
  26. Topographic patterns of intestinal metaplasia and gastric cancer. Am J Gastroenterol. 2000 Jun; 95(6):1431-8.
    View in: PubMed
    Score: 0.010
  27. Microsatellite instability in gastric intestinal metaplasia in patients with and without gastric cancer. Am J Pathol. 2000 Feb; 156(2):537-43.
    View in: PubMed
    Score: 0.010
  28. Molecular relationships of Helicobacter pylori strains in a family with gastroduodenal disease. Am J Gastroenterol. 1999 Feb; 94(2):364-8.
    View in: PubMed
    Score: 0.009
  29. Intestinal metaplasia with adherent Helicobacter pylori: a hybrid epithelium with both gastric and intestinal features. Hum Pathol. 1998 Aug; 29(8):846-50.
    View in: PubMed
    Score: 0.009
  30. Adherence of Helicobacter pylori to areas of incomplete intestinal metaplasia in the gastric mucosa. Gastroenterology. 1996 Nov; 111(5):1206-11.
    View in: PubMed
    Score: 0.008
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.